
Sign up to save your podcasts
Or
In this episode of Quality Matters, Dr. Richard Bergenstal, Executive Director of the International Diabetes Center, joins host Andy Reynolds to explore the evolving landscape of diabetes care—from the legacy of A1C to the promise of continuous glucose monitoring (CGM).
Rich shares lessons from decades of clinical leadership, research and quality improvement, including his advisory role in NCQA’s updated Diabetes Recognition Program. He explains how CGM, new metrics like the Glucose Management Indicator and a focus on patient experience are reshaping how we define and deliver high-quality diabetes care.
Listen to this episode to discover:
This conversation is essential for quality leaders, clinicians and health plan professionals who want to stay ahead of the curve in diabetes care, digital health and patient-centered quality improvement.
Key Quote:
The A1C set up the need for the next technology. Why did finger stick glucose come about? Because the average A1C said, “You need to do better.”
But nobody wants to poke their finger multiple times a day. So A1C led to finger sticks. Finger sticks led to CGM and now CGM has changed the dialogue. The A1C era had its role, but you look for the next thing to get to the next level. That's what I see CGM as.
-Rich Bergenstal, MD
Time Stamps:
(02:14) The Era of A1C
(04:22) What is Continuous Glucose Monitoring (CGM)
(06:43) Bridging the A1C and CGM Eras
(10:45) Addressing Skepticism and Myths about CGM
(18:37) The Future of Diabetes Care
Dive Deeper:
NCQA’s Diabetes Recognition Program
Recent Quality News About Diabetes
Connect with Rich Bergenstal
4.6
3434 ratings
In this episode of Quality Matters, Dr. Richard Bergenstal, Executive Director of the International Diabetes Center, joins host Andy Reynolds to explore the evolving landscape of diabetes care—from the legacy of A1C to the promise of continuous glucose monitoring (CGM).
Rich shares lessons from decades of clinical leadership, research and quality improvement, including his advisory role in NCQA’s updated Diabetes Recognition Program. He explains how CGM, new metrics like the Glucose Management Indicator and a focus on patient experience are reshaping how we define and deliver high-quality diabetes care.
Listen to this episode to discover:
This conversation is essential for quality leaders, clinicians and health plan professionals who want to stay ahead of the curve in diabetes care, digital health and patient-centered quality improvement.
Key Quote:
The A1C set up the need for the next technology. Why did finger stick glucose come about? Because the average A1C said, “You need to do better.”
But nobody wants to poke their finger multiple times a day. So A1C led to finger sticks. Finger sticks led to CGM and now CGM has changed the dialogue. The A1C era had its role, but you look for the next thing to get to the next level. That's what I see CGM as.
-Rich Bergenstal, MD
Time Stamps:
(02:14) The Era of A1C
(04:22) What is Continuous Glucose Monitoring (CGM)
(06:43) Bridging the A1C and CGM Eras
(10:45) Addressing Skepticism and Myths about CGM
(18:37) The Future of Diabetes Care
Dive Deeper:
NCQA’s Diabetes Recognition Program
Recent Quality News About Diabetes
Connect with Rich Bergenstal
90,400 Listeners
30,695 Listeners
1,471 Listeners
254 Listeners
111,059 Listeners
55,993 Listeners
478 Listeners
24,045 Listeners
185 Listeners
4,484 Listeners
393 Listeners
1,379 Listeners
15,495 Listeners
10,646 Listeners
162 Listeners